Opaleye Management’s Biodesix BDSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.45M Buy
+238,047
New +$2.95M 0.45% 38
2025
Q2
Sell
-161,250
Closed -$2.02M 43
2025
Q1
$2.02M Sell
161,250
-12,000
-7% -$230K 0.45% 32
2024
Q4
$5.3M Sell
173,250
-17,500
-9% -$515K 0.93% 23
2024
Q3
$6.97M Sell
190,750
-10,250
-5% -$353K 1.16% 18
2024
Q2
$6.15M Buy
201,000
+174,267
+652% +$4.98M 1.41% 23
2024
Q1
$765K Buy
26,733
+1,908
+8% +$65.3K 0.17% 49
2023
Q4
$3.61M Buy
24,825
+2,046
+9% +$64.2K 0.96% 26
2023
Q3
$3.04M Buy
+22,779
New +$632K 0.99% 29

Other funds holding BDSX

Opaleye Management's BDSX Position: Q1 2026 in Review

Opaleye Management opened a new position in Biodesix (BDSX) in Q1 2026: 238,047 shares worth $3.45M. The stake represents 0.45% of the portfolio and ranks #38 among its holdings. This is a return to the name: Opaleye Management previously reported a position in BDSX as recently as Q1 2025.

Opaleye Management first reported a position in BDSX in Q3 2023 and has held it in 8 quarters since. The position peaked at $6.97M in Q3 2024. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • Opaleye Management held 238,047 shares of Biodesix worth $3.45M as of Q1 2026.
  • Biodesix was a new Opaleye Management position in Q1 2026.
  • Biodesix made up 0.45% of Opaleye Management's portfolio in Q1 2026, its #38 holding.
  • Opaleye Management first reported a position in Biodesix in Q3 2023 and has held it in 8 quarters since.
  • Opaleye Management's Biodesix position peaked at $6.97M in Q3 2024.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Opaleye Management's 13F filing for Q1 2026, filed 15 May 2026.